Key takeaways
- Morpheus8 is 510(k)-cleared for coagulation/contraction of soft tissue or hemostasis, not FDA-approved for wrinkles, scars or fat reduction.
- FDA's October 15, 2025 Safety Communication lists burns, scarring, fat loss, disfigurement and nerve damage reported with RF microneedling.
- MAUDE percentages are shares of reported events, not the odds that any one patient is harmed.
- Studies report mostly mild, transient effects; the report record is harsher, and no source explains the gap.
- FDA advises a licensed provider trained on the device, and asking which device will be used.
What can go wrong with Morpheus8?
Morpheus8 is an InMode applicator family cleared by FDA through the 510(k) process for devices, not the approval process for drugs.
The first clearance under the Morpheus8 name, K192695, was decided on December 27, 2019.
The current one, K231790, covers use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed, and words like wrinkles, acne scars, jowl tightening, fat reduction and cellulite do not appear in that cleared text.
Calling Morpheus8 "FDA-approved" misstates the clearance.
The complaints behind the "ruined my skin" posts describe, in their serious forms, harms FDA has formally flagged.
On October 15, 2025, the agency issued a Safety Communication reporting burns, scarring, fat loss, disfigurement and nerve damage, sometimes needing surgical repair or medical intervention, with RF microneedling used for aesthetic skin procedures.
Morpheus8 is an RF microneedling device, so the technology that communication addresses is the technology behind the complaints.
How often these injuries happen is the part no source pins down.
In studies the record looks milder: a 2026 systematic review of RF microneedling for facial rejuvenation, covering 20 studies and 558 participants, found adverse events were mostly mild and transient, with erythema and swelling the most common and no serious complications in the included studies.
Some of that review's authors work for or speak for an RF device maker, which is worth knowing when you weigh it.
Reports filed in FDA's MAUDE database tell a harsher real-world story, and they are the next section's subject.
FDA reported serious complications with RF microneedling used for aesthetic skin procedures: burns, scarring, fat loss, disfigurement and nerve damage, sometimes needing surgical repair or medical intervention. FDA calls RF microneedling "a medical procedure, not a cosmetic treatment," says the devices should not be used at home, and advises seeking a licensed health care provider trained on the device.
Grid marks, burns and hyperpigmentation
"Grid marks" is the name people use for the visible pattern of dots, lines or changed texture in some after photos.
We did not find a source that tracks grid marks as their own category, so the honest answer comes from the closest documented groups: textural changes, burns and pigment changes.
A 2026 Dermatologic Surgery analysis of FDA's MAUDE database, covering January 2013 to October 2025, identified 114 RF microneedling reports containing 224 events.
The most frequent were textural changes (25.0% of events), pigment changes (18.3%) and fat loss (11.6%), followed by inflammatory reactions, burns (6.3%) and pain.
A second 2026 MAUDE analysis counted 86 device reports with 145 adverse events from 2020 to 2025 and found fat loss, scarring and post-inflammatory erythema most reported.
Most frequent RF microneedling events in MAUDE reports
Share of 224 reported events, January 2013 to October 2025
Source: Dermatologic Surgery, 2026. Shares of reported events, not incidence rates.
Those percentages carry a caution the analysis itself makes: they are shares of reported events, not incidence rates.
MAUDE collects reports, not examinations, so the figures show which kinds of harm appear in reports, not how likely any one patient is to experience them.
On pigment specifically, a 2023 review of RF and RF microneedling in Fitzpatrick skin types III-VI, covering 35 articles, found mostly transient post-inflammatory hyperpigmentation across 7 studies, one study with prolonged hyperpigmentation and one with permanent scarring, and called much of the evidence low quality.
Burns appear both in FDA's 2025 warning and as 6.3% of the events in the 2013-to-2025 report analysis.
Facial fat loss concerns
Fat loss changes the face's shape rather than its surface.
It is on FDA's 2025 list of serious complications reported with RF microneedling.
In the MAUDE analysis covering 2013 to 2025, fat loss accounted for 11.6% of the 224 reported events; the second analysis, covering 2020 to 2025, named fat loss, scarring and post-inflammatory erythema as its most reported effects.
The cleared paperwork matters here too.
The Morpheus8 indication text covers coagulation/contraction of soft tissue or hemostasis; fat reduction is not named in it.
So the documented record connects RF microneedling to reported fat loss as a complication, not as a cleared purpose.
How often fat loss happens, at which settings, or whether it reverses is not something our sources quantify.
One surgical series adds a longer-horizon note.
In a single surgeon's review of 180 neck lifts, patients with prior nonsurgical neck treatments, Morpheus8 and other RF devices, Kybella and CoolSculpting among them, showed fibrosis and loss of normal tissue planes, with longer operations and frequent contour irregularities.
It is one surgeon's retrospective series with mixed treatments, so it cannot pin those findings on Morpheus8 alone.
If facial fat loss is your main worry, name it at a consultation and ask how the planned treatment relates to it.
FDA's 510(k) database is public, and consumers can look up a device's cleared indication in it. Whatever a clinic's brochure promises beyond that wording is the clinic's claim, not the device's label.
Find Morpheus8 providers near you
Compare Google ratings, reviews and posted prices at med spas in your city.
Why settings and provider skill matter
The clearest settings fact sits in the device's own labeling.
Every Morpheus8 510(k) clearance limits use at energy levels above 62 mJ per pin to Fitzpatrick skin types I-IV, so darker skin types V-VI are within the labeling only at lower energies.
Energy settings are not a stylistic choice; the clearance ties them to skin type.
The study record and the report record also differ.
The 2026 systematic review's findings, mostly mild and transient events with no serious complications in the included studies, describe what happened under study conditions.
FDA's complication reports describe what happened once the devices reached the wider market.
The same category of device sits in both records, and none of our sources explains the difference, so treat a provider's answers on who treats you, on what settings and with what training as questions worth asking, not as a guarantee.
Study record (2026 systematic review)
- 20 studies, 558 participants
- Adverse events mostly mild and transient
- Erythema and swelling most common
- No serious complications in the included studies
Report record (FDA, 2025)
- Devices in wider market use
- Burns, scarring, fat loss, disfigurement and nerve damage reported
- Some cases needed surgical repair or medical intervention
FDA's own advice points the same way.
The agency says to seek care from a licensed health care provider with training and experience on RF microneedling devices, and to ask which device will be used.
Morpheus8 is a prescription-use device per its 510(k) Indications for Use form.
What to do if you had a bad result
This page cannot tell you how to treat a complication.
That is a medical judgment for a professional who can examine your skin, and a guide that guessed at it would be guessing with your face.
What the sourced record supports saying is narrower: FDA describes RF microneedling as a medical procedure rather than a cosmetic treatment, and advises care from a licensed health care provider with training and experience on these devices.
Contact the provider who treated you, and have a qualified professional look at what changed.
The same FDA report is the reason not to minimize what you can see or feel: the complications it lists, including burns, scarring, fat loss, disfigurement and nerve damage, sometimes required surgical repair or medical intervention, per the agency.
On how reported problems behave over time, the study record is limited.
The 2023 review in skin types III-VI found pigment changes mostly transient across 7 studies, alongside one study with prolonged hyperpigmentation and one with permanent scarring, and it judged much of the evidence low quality.
That is what 35 articles recorded, not a prediction for your case.
No sourced figure says how often complaints resolve, so we will not invent one.
2023 review of RF and RF microneedling in skin types III-VI (35 articles)
| Finding | Studies reporting it |
|---|---|
| Transient post-inflammatory hyperpigmentation | 7 |
| Prolonged hyperpigmentation | 1 |
| Permanent scarring | 1 |
Choosing a qualified Morpheus8 provider
Choosing a provider does not make the risks on this page go away, but it is the part you control.
FDA's consumer advice is the checklist to start from.
Seek a licensed health care provider with training and experience on RF microneedling devices, ask which device will be used, and treat "how will you set this for my skin type?" as a normal question, because the labeling itself limits energies above 62 mJ per pin to skin types I-IV.
A provider who answers plainly, naming the device, the tip, the settings and what the clearance actually says, is answering the questions above.
Our guide to choosing a med spa covers the full vetting checklist, and the Morpheus8 guide covers the clearance wording, sessions and cost in depth.
Frequently asked questions
Can Morpheus8 cause fat loss in your face?
Fat loss is on FDA's 2025 list of serious complications reported with RF microneedling.
In the report analyses, one MAUDE review counted fat loss as 11.6% of 224 reported events, and a second named fat loss, scarring and post-inflammatory erythema its most reported effects.
Those are shares of reports, not rates, so they do not tell you how likely it is.
Whether a planned treatment could affect facial fat is a question to put to a licensed provider, by name, before you book.
Are Morpheus8 grid marks permanent?
No source we found tracks grid marks as their own category, so there is no permanence rate to quote.
The closest documented group is textural change, the most frequent event type in the 2013 to 2025 MAUDE analysis at 25.0% of reported events.
In a 2023 review of skin types III-VI, most reported pigment changes were transient, but one study reported prolonged hyperpigmentation and one reported permanent scarring.
Whether marks fade for you is a question for a provider who can examine your skin.
Is Morpheus8 safe?
There is no blanket answer, and the record splits in a way worth understanding.
A 2026 systematic review of RF microneedling in general (20 studies, 558 participants) found adverse events mostly mild and transient, with no serious complications reported in the included studies, though some review authors are tied to a device maker.
FDA, meanwhile, issued a 2025 safety communication listing burns, scarring, fat loss, disfigurement and nerve damage reported with RF microneedling, and calls RF microneedling a medical procedure rather than a cosmetic one.
No source we found says it carries no risk, and whether it suits you is a licensed provider's judgment after an examination.
What should I ask a Morpheus8 provider before booking?
FDA's advice covers the basics: seek a licensed health care provider with training and experience on RF microneedling devices, and ask which device will be used.
Morpheus8 is a prescription-use device.
Because the labeling limits energy above 62 mJ per pin to Fitzpatrick skin types I-IV, ask how the planned settings fit your skin type and what recovery looks like at those settings.
A provider who answers specifically is telling you something useful.
Sources
Every number on this page comes from one of these sources and was checked against it.
- accessdata.fda.gov · U.S. Food and Drug Administration
- accessdata.fda.gov · U.S. Food and Drug Administration
- accessdata.fda.gov · U.S. Food and Drug Administration
- Potential Risks with Certain Uses of Radiofrequency Microneedling · U.S. Food and Drug Administration
- Analysis of US Food and Drug Administration Data on Radiofrequency Microneedling Device Complications · Chou et al., Dermatol Surg, 2026
- Safety Considerations and Complications With Radiofrequency Microneedling: A Cross-Sectional Analysis of the US FDA MAUDE Database · Camacho-Hubbard et al., Dermatol Surg, 2026
- Radiofrequency Microneedling for Facial Rejuvenation: A Systematic Review · Kumar et al., J Cosmet Dermatol, 2026
- Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy · Syder et al., Dermatol Surg, 2023
- Neck Lift After Nonsurgical Treatments: Fibrosis, Fat Loss, and Surgical Complexity · O'Daniel et al., Aesthet Surg J, 2026
Medical disclaimer. MedSpaStandard is for education only and is not medical advice. Talk to a licensed provider about your own health, and check any provider's license with your state board.